Showing results (1481-1490 of 1,868) with videos related to

Sort By:
Pageof 187
Cancer Immunology, Immunotherapy : CII|August 11, 2006
Regulation of galectin-1 expression by transforming growth factor beta1 in metastatic mammary adenocarcinoma cells: implications for tumor-immune escapeCecilia M Daroqui, Juan M Ilarregui, Natalia Rubinstein, et al.
Endocrine Connections|July 5, 2019
Growth hormone upregulates the pro-tumorigenic galectin 1 in mouse liverMaría L Bacigalupo, Verónica G Piazza, Nadia S Cicconi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 2, 2015
Trypanosoma cruzi Infection Imparts a Regulatory Program in Dendritic Cells and T Cells via Galectin-1-Dependent MechanismsCarolina V Poncini, Juan M Ilarregui, Estela I Batalla, et al.
Biotechnology Journal|March 22, 2007
Application of cellulose-based self-assembled tri-enzyme system in a pseudo-reagent-less biosensor for biogenic catecholamine detectionMikhail L Rabinovich, Liliya G Vasil'chenko, Karen N Karapetyan, et al.
Frontiers in Molecular Biosciences|May 11, 2026
Variant allele frequency as a predictor of treatment response to osimertinib in EGFR-mutated NSCLCWalid Shalata, Bilal Krayim, Asmah Miari, et al.
The Journal of Biological Chemistry|July 17, 2024
Different roles of the heterodimer architecture of galectin-4 in selective recognition of oligosaccharides and lipopolysaccharides having ABH antigensJon I Quintana, Mora Massaro, Alejandro J Cagnoni, et al.
The American Journal of Tropical Medicine and Hygiene|September 18, 2024
Training of Field-Workers for Rapid Assessment of Scabies Prevalence: A Diagnostic Accuracy Study in MozambiqueJoanna Furnival-Adams, Valeria López, Hansel Mundaca, et al.
Glycobiology|December 18, 2004
Galectin-3 and soluble fibrinogen act in concert to modulate neutrophil activation and survival: involvement of alternative MAPK pathwaysGabriela C Fernández, Juan M Ilarregui, Carolina J Rubel, et al.
BMC Cancer|August 30, 2008
Native human autoantibodies targeting GIPC1 identify differential expression in malignant tumors of the breast and ovaryVictoria Yavelsky, Sarit Rohkin, Ruthy Shaco-Levy, et al.
Pageof 187